•
Sep 30, 2023

IGM Biosciences Q3 2023 Earnings Report

Total Revenue
$509K
Previous year: $331K
+53.8%
EPS
-$1.04
Previous year: -$1.32
-21.2%
Gross Profit
-$1.75M
Cash and Equivalents
$388M
Previous year: $177M
+118.5%
Free Cash Flow
-$43.2M
Previous year: -$43.1M
+0.2%
Total Assets
$474M
Previous year: $541M
-12.3%

IGM Biosciences

IGM Biosciences